Budesonide/formoterol - Teva Pharmaceutical Industries

Drug Profile

Budesonide/formoterol - Teva Pharmaceutical Industries

Alternative Names: BF Spiromax®; BiResp Spiromax; Budesonide/formoterol - Teva; Budesonide/formoterol fumarate dihydrate Spiromax®; DuoResp Spiromax; Formoterol/budesonide - Teva; Vylaer Spiromax

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teva Pharmaceutical Industries
  • Class Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Pregnenediones; Small molecules
  • Mechanism of Action Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma; Chronic obstructive pulmonary disease

Most Recent Events

  • 12 Sep 2017 Launched for Asthma (In adults) and Chronic obstructive pulmonary disease (In adults) in South Korea, Israel, Russia (Inhalation) before September 2017
  • 12 Sep 2017 Launched for Asthma (In adults) and Chronic obstructive pulmonary disease (In adults) in Slovenia, Netherlands, Latvia, Italy, France, Croatia, Bulgaria (Inhalation) before September 2017
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top